Brunelle, Cheryl L. https://orcid.org/0000-0001-6986-5094
Taghian, Alphonse G.
Funding for this research was provided by:
National Cancer Institute (R01CA139118)
National Cancer Institute (P50CA08393)
The Olayan-Xefos Family Fund for Breast Cancer Research
Heinz Family Foundation
The Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema
Article History
Accepted: 27 December 2022
First Online: 30 January 2023
Declarations
:
: Cheryl L. Brunelle reports grants from Award Number R01CA139118 (AG Taghian); National Cancer Institute, grants from Award Number P50CA08393 (AG Taghian); National Cancer Institute, from the Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema (AG Taghian), from the Olayan-Xefos Family Fund for Breast Cancer Research (AG Taghian), and from the Heinz Family Foundation (AG Taghian), during the conduct of the study, and personal fees from PureTech Health, outside the submitted work.Alphonse G. Taghian reports grants from Award Number R01CA139118, National Cancer Institute, grants from Award Number P50CA08393, National Cancer Institute, from the Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema (AG Taghian), from the Olayan-Xefos Family Fund for Breast Cancer Research, and from the Heinz Family Foundation, during the conduct of the study; Dr. Taghian is on the Scientific Advisory Board for PureTech Health and has received consulting fees from Vision RT and non-financial support from ImpediMed, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.